JP2014501716A5 - - Google Patents

Download PDF

Info

Publication number
JP2014501716A5
JP2014501716A5 JP2013538794A JP2013538794A JP2014501716A5 JP 2014501716 A5 JP2014501716 A5 JP 2014501716A5 JP 2013538794 A JP2013538794 A JP 2013538794A JP 2013538794 A JP2013538794 A JP 2013538794A JP 2014501716 A5 JP2014501716 A5 JP 2014501716A5
Authority
JP
Japan
Prior art keywords
hydroxyamino
methyl
benzamide
hydroxymethyl
diynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013538794A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014501716A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/059280 external-priority patent/WO2012154204A1/en
Publication of JP2014501716A publication Critical patent/JP2014501716A/ja
Publication of JP2014501716A5 publication Critical patent/JP2014501716A5/ja
Pending legal-status Critical Current

Links

JP2013538794A 2010-11-10 2011-11-04 ヒドロキサム酸誘導体および細菌感染の処置におけるその使用 Pending JP2014501716A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41231110P 2010-11-10 2010-11-10
US61/412,311 2010-11-10
PCT/US2011/059280 WO2012154204A1 (en) 2010-11-10 2011-11-04 Hydroxamic acid derivatives and their use in the treatment of bacterial infections

Publications (2)

Publication Number Publication Date
JP2014501716A JP2014501716A (ja) 2014-01-23
JP2014501716A5 true JP2014501716A5 (cg-RX-API-DMAC7.html) 2014-12-18

Family

ID=46317476

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013538794A Pending JP2014501716A (ja) 2010-11-10 2011-11-04 ヒドロキサム酸誘導体および細菌感染の処置におけるその使用

Country Status (14)

Country Link
EP (1) EP2638006A1 (cg-RX-API-DMAC7.html)
JP (1) JP2014501716A (cg-RX-API-DMAC7.html)
KR (1) KR20140023869A (cg-RX-API-DMAC7.html)
CN (1) CN103298780A (cg-RX-API-DMAC7.html)
AR (1) AR083760A1 (cg-RX-API-DMAC7.html)
AU (1) AU2011367819A1 (cg-RX-API-DMAC7.html)
BR (1) BR112013011693A2 (cg-RX-API-DMAC7.html)
CA (1) CA2817211A1 (cg-RX-API-DMAC7.html)
EA (1) EA201390626A1 (cg-RX-API-DMAC7.html)
IL (1) IL226270A0 (cg-RX-API-DMAC7.html)
MX (1) MX2013005200A (cg-RX-API-DMAC7.html)
SG (1) SG190243A1 (cg-RX-API-DMAC7.html)
TW (1) TW201249786A (cg-RX-API-DMAC7.html)
WO (1) WO2012154204A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101765585B (zh) 2007-06-12 2017-03-15 尔察祯有限公司 抗菌剂
WO2013170030A1 (en) * 2012-05-09 2013-11-14 Achaogen, Inc. Antibacterial agents
EP2847168A1 (en) 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
ES2666130T3 (es) 2013-12-19 2018-05-03 Idorsia Pharmaceuticals Ltd Derivados antibacterianos de 1H-indazol y 1H-indol
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
US9539305B1 (en) 2014-03-14 2017-01-10 Fleurir Abx Llc Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
WO2015173329A1 (en) 2014-05-16 2015-11-19 Actelion Pharmaceuticals Ltd Antibacterial quinazoline-4(3h)-one derivatives
AU2015349005A1 (en) 2014-11-19 2017-07-06 Idorsia Pharmaceuticals Ltd Antibacterial benzothiazole derivatives
EA032138B1 (ru) 2014-12-16 2019-04-30 Новартис Аг СОЕДИНЕНИЯ ИЗОКСАЗОЛГИДРОКСАМИНОВОЙ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ LpxC
US11034649B2 (en) 2016-04-25 2021-06-15 Duke University Benzoylglycine derivatives and methods of making and using same
MA45250B1 (fr) 2016-06-14 2020-09-30 Novartis Ag Forme crystalline de (r)-4-(5-(cyclopropyléthynyl)isoxazol-3-yl)-n-hydroxy-2-méthyl-2-(méthylsulfonyl)butanamide en tant qu'agent antibacteriel
AR108864A1 (es) 2016-06-23 2018-10-03 Achaogen Inc Agentes antibacterianos
US11498909B2 (en) * 2018-02-10 2022-11-15 Kbp Biosciences Co., Ltd. Compound acting as antibiotics
CN110563611B (zh) * 2019-09-19 2021-02-02 中国医学科学院医药生物技术研究所 一种异羟肟酸类衍生物及其制备方法和应用
CN113957098A (zh) * 2021-09-13 2022-01-21 湖南工业大学 普罗威登斯属细菌菌株在制备二价锰氧化剂中的应用
CN116730870B (zh) * 2023-08-08 2023-10-13 中国医学科学院医药生物技术研究所 异羟肟酸类化合物或其可药用盐、及其用途和制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925659A (en) 1996-05-07 1999-07-20 Merck & Co., Inc. Antibacterial agents
US6541276B2 (en) 1996-10-28 2003-04-01 Versicor, Inc. Methods for solid-phase synthesis of hydroxylamine compounds and derivatives and combinatorial libraries thereof
EP1169031A1 (en) 1999-04-09 2002-01-09 British Biotech Pharmaceuticals Limited Antimicrobial agents
SG2012000667A (en) * 2003-01-08 2015-03-30 Univ Washington Antibacterial agents
DE102006032709A1 (de) 2006-07-14 2008-01-17 BSH Bosch und Siemens Hausgeräte GmbH Luftschallgedämmte Lebensmittelmühle
CN101209974A (zh) * 2006-12-31 2008-07-02 天津药物研究院 异羟肟酸类衍生物及其用途
CN101765585B (zh) * 2007-06-12 2017-03-15 尔察祯有限公司 抗菌剂
WO2011005355A1 (en) * 2009-05-07 2011-01-13 Achaogen, Inc. Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
NZ603198A (en) * 2010-04-20 2013-10-25 Taisho Pharmaceutical Co Ltd Novel hydroxamic acid derivative

Similar Documents

Publication Publication Date Title
JP2014501716A5 (cg-RX-API-DMAC7.html)
JP2012502946A5 (cg-RX-API-DMAC7.html)
US11352315B2 (en) Compositions and methods comprising a triaryl polyamine
JP2003506354A5 (cg-RX-API-DMAC7.html)
RU2014134720A (ru) Противомикробные композиции, содержащие dgla, 15-онера и/или 15-hetre, и способы их применения
JP2016535795A5 (cg-RX-API-DMAC7.html)
EA201400358A1 (ru) Замещенные n-[1-циано-2-(фенил)этил]-2-азабицикло[2.2.1]гептан-3-карбоксамидные ингибиторы катепсина с
JP2015502974A5 (cg-RX-API-DMAC7.html)
EP2662353A3 (en) Antibacterial agents
JP2009523760A5 (cg-RX-API-DMAC7.html)
JP2012522037A5 (cg-RX-API-DMAC7.html)
US8507647B2 (en) Antibacterial agents for the treatment of gram positive infections
EA200970535A1 (ru) Антибактериальные производные хинолина
US10464896B2 (en) Efflux-pump inhibitors and therapeutic uses thereof
AU2012296543A1 (en) Methods of treating bacterial infections with 1,2-benzisothiazolinone and isoindolinone derivatives
SE1551572A1 (sv) Compounds and methods of treating bacterial infections
EA200970534A1 (ru) Антибактериальные производные хинолина
WO2008127300A3 (en) Oxazolidinone derivatives and methods of use
PH12020551772A1 (en) Oxo-substituted compound
WO2020117755A1 (en) Compositions and methods for treating biofilms
WO2008028805A3 (de) Verwendung einer pharmazeutischen zusammensetzung enthaltend ein anticholinergikum zur abtötung von mikroorganismen und zur behandlung von atemwegsinfektionen
WO2008094912B1 (en) Substituted gamma lactams as therapeutic agents
JP2012031152A5 (cg-RX-API-DMAC7.html)
US20240261257A1 (en) Methods of treating bacterial infections
CN105792827B (zh) 抗菌组合物